These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 27506744)

  • 1. Role of metabolism in neurodegenerative disorders.
    Procaccini C; Santopaolo M; Faicchia D; Colamatteo A; Formisano L; de Candia P; Galgani M; De Rosa V; Matarese G
    Metabolism; 2016 Sep; 65(9):1376-90. PubMed ID: 27506744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and ghrelin: Sewing metabolism onto neurodegeneration.
    de Candia P; Matarese G
    Neuropharmacology; 2018 Jul; 136(Pt B):307-316. PubMed ID: 29248481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders.
    Stoyanova II
    Neurobiol Dis; 2014 Dec; 72 Pt A():72-83. PubMed ID: 25173805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus and Energy Dysmetabolism in Alzheimer's Disease: Understanding the Relationships and Potential Therapeutic Targets.
    Onaolapo AY; Ojo FO; Adeleye OO; Falade J; Onaolapo OJ
    Curr Diabetes Rev; 2023; 19(8):e020123212333. PubMed ID: 36593701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin and Neurodegenerative Disorders-a Review.
    Shi L; Du X; Jiang H; Xie J
    Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration.
    Spielman LJ; Little JP; Klegeris A
    J Neuroimmunol; 2014 Aug; 273(1-2):8-21. PubMed ID: 24969117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage in neurodegenerative diseases.
    Coppedè F; Migliore L
    Mutat Res; 2015 Jun; 776():84-97. PubMed ID: 26255941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles in neurodegenerative diseases.
    Croese T; Furlan R
    Mol Aspects Med; 2018 Apr; 60():52-61. PubMed ID: 29137922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical correlation between major depressive disorder and neurodegenerative diseases.
    Réus GZ; Titus SE; Abelaira HM; Freitas SM; Tuon T; Quevedo J; Budni J
    Life Sci; 2016 Aug; 158():121-9. PubMed ID: 27370938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated microRNAs in neurodegenerative disorders.
    Lau P; de Strooper B
    Semin Cell Dev Biol; 2010 Sep; 21(7):768-73. PubMed ID: 20080199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically modified pig models for neurodegenerative disorders.
    Holm IE; Alstrup AK; Luo Y
    J Pathol; 2016 Jan; 238(2):267-87. PubMed ID: 26446984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end-products in neurodegenerative diseases.
    Juranek J; Ray R; Banach M; Rai V
    Rev Neurosci; 2015; 26(6):691-8. PubMed ID: 26226128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and neurodegenerative disease: shared and specific mechanisms.
    Craft S; Watson GS
    Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.
    McDonald TS; Lerskiatiphanich T; Woodruff TM; McCombe PA; Lee JD
    J Cereb Blood Flow Metab; 2023 Jan; 43(1):26-43. PubMed ID: 36281012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the bakery to the brain business: developing inducible yeast models of human neurodegenerative disorders.
    Ocampo A; Barrientos A
    Biotechniques; 2008 Oct; 45(4):vii-xiv. PubMed ID: 18855765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.